Latest Forum Topics / OUE Lippo HC Last:0.033 -- |
![]() |
IHC
|
|||||
BenBen1823
Member |
01-Jul-2022 09:22
|
||||
x 0
x 0 Alert Admin |
Is this counter a good buy? | ||||
Useful To Me Not Useful To Me | |||||
SmallSmall
Supreme |
01-Jul-2022 09:06
|
||||
x 0
x 0 Alert Admin |
UPDATE ON THE PROPOSED PARTNERSHIP WITH GROUP OF RESPIRATORY AND CARDIOTHORACIC MEDICAL PRACTICES IN SINGAPORE Unless otherwise defined, all capitalised terms used herein shall have the meanings ascribed to them in the announcement dated 23 May 2022 (the " 23 May Announcement" ). The Board of Directors (the " Board" ) of OUE Lippo Healthcare Limited (the " Company" ) refers to the 23 May Announcement in relation to the (a) establishment of a joint venture company known as Echo Healthcare Management Pte. Ltd. (the " OUE JV" ) with OUE Limited and (b) proposed formation of a joint venture with (i) RMA Med Holdings Pte. Ltd. (" RMA HoldCo" ) (ii) TRP Holdings Pte. Ltd. (" TRP HoldCo" ) and (iii) Witty Hearty Lungs Pte. Ltd. (" BH HoldCo" and together with RMA HoldCo and TRP HoldCo, the " Founders" ) to create a partnership with (i) RMA Global Pte. Ltd. (" RMA" ), (ii) The Respiratory Practice (Farrer) Pte. Ltd. (" TRPF" ), and (iii) Breathing Heart Pte. Ltd. (" BH" , and together with RMA and TRPF, the " Medical Partners" ) (the " Proposed Transaction" ). The Board is pleased to announce that all the conditions precedent under the MSSPA have been fulfilled and/or waived in accordance with the terms of the MSSPA, and accordingly, the Proposed Transaction was completed today. |
||||
Useful To Me Not Useful To Me | |||||
|
|||||
SmallSmall
Supreme |
16-Jun-2022 08:54
|
||||
x 0
x 0 Alert Admin |
FULL & FINAL SETTLEMENT WITH CREST ENTITIES ON PROCEEDINGS RELATED TO FACILITY AGREEMENTS 
 
The Company has received the above balance payment of S$200,000 from Crest. Upon receipt of the said balance payment, there are no further outstanding instalments due from Crest under the Settlement Agreement. There are also no other pending or outstanding claims between the Company and Crest. 
|
||||
Useful To Me Not Useful To Me | |||||
ThankYou
Supreme |
07-Jun-2022 09:46
|
||||
x 0
x 0 Alert Admin |
Never move up much only 38. Limited range.
|
||||
Useful To Me Not Useful To Me | |||||
SmallSmall
Supreme |
07-Jun-2022 09:33
|
||||
x 0
x 0 Alert Admin |
Rebound. Day trade?  | ||||
Useful To Me Not Useful To Me | |||||
|
|||||
SmallSmall
Supreme |
25-May-2022 10:10
|
||||
x 0
x 0 Alert Admin |
RATIONALE AND KEY BENEFITS OF THE PROPOSED TRANSACTION The Board believes that the Proposed Transaction is in the interests of the Company for the following reasons: (a) Building a regional healthcare ecosystem anchored on Singapore&rsquo s medical best practices The Proposed Transaction is an important milestone for the Company to build a regional healthcare ecosystem anchored on Singapore&rsquo s medical best practices and create potential synergistic growth opportunities. The Company will be able to leverage on the Medical Partners&rsquo clinical expertise to elevate the overall healthcare standards and quality in the Company&rsquo s growing regional healthcare network. ( b) Win-win arrangement in ensuring sustainable regional growth for all stakeholders The Proposed Transaction is structured such that while the Medical Partners will be integrated into the Company' s healthcare network, they will retain clinical independence in their respective practices, thereby aligning long-term objective of all stakeholders to ensure sustainable growth. ( c) Enhances shareholder value Based on the Medical Partners' financial results for the past three (3) financial years, the Medical Partners are earnings accretive with a stable and growing stream of recurring income and cash flow, which the Company envisages will enhance long term shareholder value. |
||||
Useful To Me Not Useful To Me | |||||
SmallSmall
Supreme |
25-May-2022 09:44
|
||||
x 0
x 0 Alert Admin |
This one will eventually be transformed into a mega healthcare play by the Lippo Group. Still gestation period. NAV $0.0551.
|
||||
Useful To Me Not Useful To Me | |||||
Joelton
Supreme |
25-May-2022 09:36
|
||||
x 0
x 0 Alert Admin |
OUE Lippo Healthcare up 5.3% on new healthcare partnership
 
SHARES of OUE Lippo Healthcare closed higher on Tuesday (May 24), after the healthcare group said it will form new partnerships to add to its healthcare network.
 
The counter gained as much as 18.4 per cent or S$0.007 to trade at S$0.045 as at 9.04 am, before closing 5.3 per cent or S$0.002 higher at S$0.04 on Tuesday.
 
No married deals were recorded, according to ShareInvestor data.
 
As at 9.43 am, its shares have eased slightly to trade at S$0.041, up 7.9 per cent or S$0.003. Some 12.3 million shares worth S$540,000 changed hands.
 
On Monday, OUE Lippo Healthcare said Echo Healthcare Management, its joint venture with OUE, has formed a partnership called Echo Healthcare Services with 3 medical specialist groups.
 
The 3 partners include Respiratory Medical Associates (RMA) and The Respiratory Practice (TRP), which provide treatment for lung, sleep and allergy disorders, and Thoracic & Cardiovascular Surgery Specialists (TCSS), which provides cardiac and thoracic surgery.
 
Echo Healthcare Management will hold a 60 per cent stake in the new joint venture, while the founders of the medical specialists groups will hold the remaining 40 per cent stake collectively.
 
Echo Healthcare Services will also hold a 60 per cent stake in each of the medical specialists groups.
 
The total aggregate purchase price for all 3 specialist medical groups is S$31 million, comprising S$6.5 million for RMA&rsquo s shares, S$8.3 million for TRP&rsquo s shares and S$16.2 million for TCSS&rsquo shares, and payable with a mix of shares and cash.
 
The board of directors expects the company to tap on the medical specialists to elevate the overall healthcare standards and quality of OUE&rsquo s regional healthcare network. The medical partners will also be integrated into the healthcare network while retaining their clinical independence in their own practices.
|
||||
Useful To Me Not Useful To Me | |||||
|
|||||
ThankYou
Supreme |
24-May-2022 14:14
|
||||
x 0
x 0 Alert Admin |
Yes!!! | ||||
Useful To Me Not Useful To Me | |||||
ThankYou
Supreme |
24-May-2022 13:45
|
||||
x 0
x 0 Alert Admin |
Any bro playing this? Can get more at 4 cents? | ||||
Useful To Me Not Useful To Me | |||||
ThankYou
Supreme |
24-May-2022 10:59
|
||||
x 0
x 0 Alert Admin |
Bought! I hope it will be played up! 🙏 🙏 🙏 | ||||
Useful To Me Not Useful To Me | |||||
ThankYou
Supreme |
24-May-2022 10:23
|
||||
x 0
x 0 Alert Admin |
EPS of 2.5 cents translates to PE 1.8 at 4.5 cents In healthcare business and got joint venture. Rise only this little? | ||||
Useful To Me Not Useful To Me | |||||
|
|||||
SmallSmall
Supreme |
24-May-2022 10:14
|
||||
x 0
x 0 Alert Admin |
SHARES of OUE Lippo Healthcare jumped in the morning on Tuesday (May 24), after the healthcare group said it will form new partnerships to add to its healthcare network. The counter gained as much as 18.4 per cent or S$0.007 to trade at S$0.045 as at 9.04 am. No married deals were recorded, according to ShareInvestor data. As at 9.43 am, its shares have eased slightly to trade at S$0.041, up 7.9 per cent or S$0.003. Some 12.3 million shares worth S$540,000 changed hands. On Monday, OUE Lippo Healthcare said Echo Healthcare Management, its joint venture with OUE, has formed a partnership called Echo Healthcare Services with 3 medical specialist groups. The 3 partners include Respiratory Medical Associates (RMA) and The Respiratory Practice (TRP), which provide treatment for lung, sleep and allergy disorders, and Thoracic & Cardiovascular Surgery Specialists (TCSS), which provides cardiac and thoracic surgery. Echo Healthcare Management will hold a 60 per cent stake in the new joint venture, while the founders of the medical specialists groups will hold the remaining 40 per cent stake collectively. Echo Healthcare Services will also hold a 60 per cent stake in each of the medical specialists groups. The total aggregate purchase price for all 3 specialist medical groups is S$31 million, comprising S$6.5 million for RMA&rsquo s shares, S$8.3 million for TRP&rsquo s shares and S$16.2 million for TCSS&rsquo shares, and payable with a mix of shares and cash. The board of directors expects the company to tap on the medical specialists to elevate the overall healthcare standards and quality of OUE&rsquo s regional healthcare network. The medical partners will also be integrated into the healthcare network while retaining their clinical independence in their own practices. |
||||
Useful To Me Not Useful To Me | |||||
ThankYou
Supreme |
24-May-2022 09:53
|
||||
x 0
x 0 Alert Admin |
Queued at 41 | ||||
Useful To Me Not Useful To Me | |||||
ThankYou
Supreme |
24-May-2022 09:43
|
||||
x 0
x 0 Alert Admin |
This share is cheap but not moving up much. So it will move up slowly one is it?
|
||||
Useful To Me Not Useful To Me | |||||
SmallSmall
Supreme |
24-May-2022 09:19
|
||||
x 0
x 0 Alert Admin |
70% held by Lippo. They are actually big in Singapore Healthcare. They also owns Healthway Med
|
||||
Useful To Me Not Useful To Me | |||||
SmallSmall
Supreme |
24-May-2022 09:15
|
||||
x 0
x 0 Alert Admin |
Chiong ah ! | ||||
Useful To Me Not Useful To Me | |||||
SmallSmall
Supreme |
24-May-2022 09:06
|
||||
x 0
x 0 Alert Admin |
OUE AND OUELH PARTNER THREE MEDICAL SPECIALIST GROUPS IN SINGAPORE FOR REGIONAL GROWTH &bull Strategic partnership with two of the leading Respiratory Specialist Practices and one Cardiothoracic Surgery Practice in Singapore &bull Building a healthcare business ecosystem anchored on Singapore&rsquo s medical best practices for regional growth Singapore - 23 May 2022 &ndash OUE Limited (&ldquo OUE&rdquo ) and its healthcare subsidiary, OUE Lippo Healthcare Limited (&ldquo OUELH&rdquo ) announced that their joint venture company known as Echo Healthcare Management Pte. Ltd. (&ldquo OUE JV&rdquo ) has formed a partnership with three medical specialist groups (the &ldquo Medical Partners&rdquo ) in Singapore. OUELH and OUE hold 60% and 40% respectively in OUE JV. Under the partnership, OUE JV and the respective founders of the Medical Partners will hold 60:40 shareholding in Echo Healthcare Services Pte. Ltd. (" HoldCo" ) respectively. HoldCo will in turn own 60% of each of the Medical Partners (&ldquo Proposed Transaction&rdquo ). The Medical Partners comprise two of the leading Respiratory Specialist Practices in Singapore - Respiratory Medical Associates and The Respiratory Practice, as well as a Cardiothoracic Surgery Practice operating as Thoracic & Cardiovascular Surgery Specialist. In total, there are 11 specialist doctors operating in the 10 clinics within the Medical Partners. Building a Sustainable Healthcare Ecosystem for Regional Growth OUELH&rsquo s regional healthcare network spans China, Myanmar, Indonesia, Japan and Singapore, providing the full spectrum of primary, secondary, tertiary and ancillary care services. Executive Chairman and Group CEO of OUE, Dr Stephen Riady said, &ldquo The partnership is an important milestone in our journey to build a regional healthcare ecosystem, comprising the full spectrum of tiered healthcare services anchored on Singapore&rsquo s medical best practices. We believe that the integration of the Medical Partners into the OUELH healthcare network will bring us one step closer to realising our vision in becoming a leading healthcare group in the region | ||||
Useful To Me Not Useful To Me | |||||
Joelton
Supreme |
16-Feb-2022 09:38
|
||||
x 0
x 0 Alert Admin |
OUE Lippo Healthcare trims H2 loss to S$2.5m, swings back to black for full year
CATALIST-LISTED OUE Lippo Healthcare $ OUE Lippo HC: 5WA +2.86% (OUELH) on Tuesday reported a net loss of S$2.5 million for the second half of the year ended December, versus a net loss of S$97.5 million in the corresponding year-ago period.
 
This translated to a loss per share of S$0.00056, versus a loss per share of S$0.02194 in H2 2020.
 
No dividend was declared for the period under review, unchanged from the previous year.
 
The company' s full-year earnings came in at S$111.4 million, reversing from a loss of S$98.7 million in the previous year.
 
Revenue for H2 inched down 1 per cent to S$10 million from S$10.1 million in the year-ago period. Cost of sales for the period was up 21 per cent to S$2.9 million from S$2.4 million.
 
For the full-year, revenue was down 2 per cent to S$19.7 million from S$20 million. OUELH' s topline, which mainly comprised rental income from its 12 nursing homes in Japan, revenue from its pharmaceutical distribution business and the Wuxi Lippo Xi Nan hospital in China, was down marginally due to the weaker exchange rate of Japanese yen to Singapore dollar.
 
Cost of sales for the year was up 6 per cent to S$5.1 million, due primarily to higher cost of sales incurred by Wuxi Lippo Xi Nan hospital as a result of ramping up its sales during the year from adapting its its services to the on-going Covid-19 pandemic.
 
The group, however, booked a 16 per cent decrease for the full year in administrative expenses due to stringent cost management and lower costs incurred in relation to corporate, merger and acquisition activities.
 
As at end-December, OUELH' s net current liabilities amounted to S$21.1 million due to a shareholder' s loan totalling $4.15 million that was accounted for as current liabilities, as well as provisions of S$22.5 million.
 
The board of directors, however, confirmed that the company is able to meet its debt obligations as and when they fall due in view of the continuing efforts by management to improve the financial position of the group.
 
In its outlook statement, OUELH said the Covid-19 pandemic continues to present challenges and uncertainties for the global economy, particularly with the recent emergence of the Omicron variant.
 
However, the company said more countries are adopting a " co-exist" approach towards the virus as global vaccination rates increase.
 
" While we are hopeful that the global economy will eventually recover, we remain cautious and will continue to monitor the global pandemic situation."
|
||||
Useful To Me Not Useful To Me | |||||
MakeChanges
Master |
16-Feb-2022 08:19
![]() Yells: "No price is too low for a bear or too high for a bull" |
||||
x 0
x 0 Alert Admin |
OUE Lippo Healthcare trims H2 loss to S$2.5m, swings back to black for full year |
||||
Useful To Me Not Useful To Me |